Bruker Corporation 6.375% Mandatory Convertible Preferred Stock Series A (BRKRP:NASDAQ) closed at $421.45 on October 23, 2026, up 0.23% on the day. The stock trades 13.1% below its 52-week high of $484.90 and 59.5% above its 52-week low of $264.30. Bruker Corporation 6.375% Mandatory Convertible Preferred Stock Series A is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, BRKRP closed higher on 122 days (48%). Its best day was May 6, 2026 (+9.98%) and its worst was August 4, 2026 (-19.90%). The stock moved 10% or more in a single session 2 times. It opened at least 5% above the previous day's high 4 times.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker BioSpin Group, Bruker Calid Group, Bruker Scientific Instruments Nano, and Bruker Energy & Supercon Technologies. The Bruker BioSpin Group and Bruker Calid Group are aggregated into BSI Life Science segment for reporting purposes, and it provides the highest revenue stream to the firm. The largest proportion of Bruker's revenue comes from Europe, though the firm also has a significant presence in the United States and Asia. It has its major technical and manufacturing centers in Europe, North America, Southeast Asia, as well as sales offices throughout the world.
Find more stocks like BRKRP with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.